Posted 12/24/2020 6:30 PM (GMT 0)
If you search the medical literature at pubmed or google scholar, I think you'll find that the majority of studies conclude that PIRADS 3 lesions, which are in the intermediate, or gray, area, should be investigated by biopsy. As you know, mpMRIs are not diagnostic of PCa, and even PIRADS 4 and 5 lesions, which are at higher risk of being malignant, sometimes turn out to be benign on biopsy. However, your PSAD is not suggestive of PCa.
I well know the problem of trying to rule PCa cancer in or out in the presence of BPH, which is likely to cause a continuously rising PSA. I can see the logic in waiting another 6 months. Yes, there are several blood and urine tests of different kinds whose results can point to a higher risk of clinically significant PCa and you can speak to your uro about them. However, if you are concerned about the risk of missing serious cancer, I think the best measure would be to biopsy.
Are you on a 5-alpha reductace inhibitor, like Proscar? If you have been, your PSA needs to be doubled (to about 7.3) to know what it would be were you not on this type of medication (I'm not sure how this class of drugs affects PSA density findings. I assume you use just use the shrunken prostate volume and the reduced PSA.)
Let's see what other Forum Brothers think. It may turn out that you do currently have low-grade/low-risk (Gleason 6) prostate cancer that could be monitored with active surveillance anyway -- i.e., not require treatment at present. In my lay opinion, I don't think a 6-month wait is a risk, but I think biopsy is likely in your near future.
All the best,
Djin